Privia Health Group Inc. (PRVA)
NASDAQ: PRVAHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PRVA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.20B
- P/E (TTM)
- 96.35
- Forward P/E
- 23.08
- EPS (TTM)
- $0.26
- Dividend yield
- None
- 52-week range
- 18.92 – 28.82
- Day range
- 24.52 – 25.40
- Volume / Avg
- 1.93M / 1.33M
- Beta
- —
- Shares outstanding
- 127.77M
52-week range
PRVA stock today
Shares of Privia Health Group (PRVA) finished higher on Nov 20 at $25.05, a gain of 1.46% or $0.36 per share, versus the S&P 500's 3.70% decline. Shares are 13.1% below their 52-week high of $28.82, set on Jul 16, 2026 and 32.4% above the 52-week low of $18.92, in the middle of the past year's range. PRVA is up 5.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 5.5%.
At 96.3x trailing earnings, Privia Health Group trades above the peer-group median of 21.6x. Its forward P/E of 23.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Privia Health Group
Company profilePrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Parth Mehrotra
- Headquarters
- Arlington, VA
- Employees
- 1,226
- IPO year
- 2021
- Website
- priviahealth.com
Financial highlights
Full financialsIn fiscal 2025, Privia Health Group generated $2.12 billion in revenue, up 22.3% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $22.9 million (+59.3% year over year), for a net margin of 1.1% versus a median of 0.8% in the prior 5 years. Operating margin was 1.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $2.12B | $1.74B | $1.66B | $1.36B | $966.22M |
| Growth | +22.26% | +4.74% | +22.19% | +40.41% | +18.25% |
| Net income | $22.92M | $14.38M | $23.08M | $-8.59M | $-188.23M |
| EPS (diluted) | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 |
Analyst forecast
ForecastConsensus (18 analysts)
strong_buy
Avg. price target
$31.35+25.15%
- Strong buy 5
- Buy 12
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.10 vs $0.09
- Surprise
- +11.11%
PRVA news
All PRVA news- Privia Health Group, Inc. Reports $374.0 Million in 2025 MSSP Shared Savings and Increases Full-Year 2026 GuidanceNasdaq
- Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings ProgramGlobeNewswire
- Privia Health Group Q3 Earnings Call HighlightsNasdaq
- Privia (PRVA) Q3 2026 Earnings Call TranscriptNasdaq
- Privia Health Group reports mixed Q3 results; raises FY26 outlookSeeking Alpha
- Privia Health Reports Strong Third Quarter and Year-to-Date 2026 ResultsGlobeNewswire
- Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP BusinessGlobeNewswire
- Privia Health to Report Third Quarter 2026 Results on Thursday, November 5GlobeNewswire
Privia Health Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HIMSHims & Hers Health Inc. Class A | 14.60 | -8.86% | $3.42B | vs PRVA |
| AVAHAveanna Healthcare Holdings Inc. | 11.01 | +2.90% | $2.40B | vs PRVA |
| ADUSAddus HomeCare Corporation | 122.50 | +1.18% | $2.28B | vs PRVA |
| OPCHOption Care Health Inc. | 31.59 | -0.06% | $4.73B | vs PRVA |
| USPHU.S. Physical Therapy Inc. | 95.93 | +1.71% | $1.43B | vs PRVA |
| WGSGeneDx Holdings Corp. Class A | 45.46 | -7.68% | $1.36B | vs PRVA |
| TDOCTeladoc Health Inc. | 7.45 | -4.36% | $1.36B | vs PRVA |
| INNVInnovAge Holding Corp. | 9.16 | +2.81% | $1.25B | vs PRVA |
Indexes, lists and sector
Privia Health Group stock FAQ
What is Privia Health Group's stock price today?
PRVA last traded at $25.05 as of Nov 20, 4:00 PM EST, up 1.46% on the day. Prices are delayed at least 15 minutes.
What is PRVA's P/E ratio?
PRVA trades at a trailing P/E ratio of 96.35 and a forward P/E of 23.08, compared with a median of 21.6 for its closest peers.
Who is Privia Health Group's CEO?
Mr. Parth Mehrotra is the chief executive officer of Privia Health Group Inc., which has about 1,226 employees.
What is the PRVA 52-week high?
The 52-week high for PRVA is $28.82 and the 52-week low is $18.92. The stock is currently 13.1% below its high.